Investors Snatch BTAI 10.0% Lower Than Its Secondary Stock Offering
October 29, 2020 at 13:22 PM EDT
Looking back to 93 days ago, BioXcel Therapeutics Inc (BTAI) priced a 4,000,000 share secondary stock offering at $50.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..